Deferasirox dispersible tablets

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/00 (2006.01) A61K 9/20 (2006.01) A61K 31/41 (2006.01)

Patent

CA 2559739

The invention pertains to dispersible tablets comprising as active ingredient deferasirox 4-[3,5-bis(2~hydroxyphenyl)-[1,2,4]triazol-l-yl]benzoic acid or pharmaceutically acceptable salt thereof in an amount of from 42% to 65% in weight by weight of the total tablet.

Il s'agit de comprimés délitables au Déférasirox dont le principe actif est l'acide 4-[3,5-bis(2-hydroxyphényl)-[1,2,4]triazol-1-yl]benzoïque ou l'un de ses sels pharmaceutiquement admis, à raison de 42 % à 65 % en masse de la masse du comprimé.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Deferasirox dispersible tablets does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Deferasirox dispersible tablets, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Deferasirox dispersible tablets will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1810758

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.